ev3 company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year



Acq - P2P | Acquired



About ev3

Ev3, Inc. was founded with the goal of building a "middle-market" alternative to its diversified, multi-billion dollar competitors in the $10 billion market for endovascular devices. Completing five acquisitions and three strategic partnerships since mid-2000, ev3 has demonstrated that a company can be large enough to support global distribution and market development without sacrificing responsiveness to technologies that address unmet or underserved clinical needs. ev3 has established positions in emerging endovascular technologies such as embolic protection, thrombectomy, stroke prevention, carotid artery stenting, and cerebral aneurysm repair. ev3 (NASDAQ: EVVV) completed its Initial Public Offering in June, 2005.

ev3 Headquarter Location

9600 54th Avenue North Suite 100

Plymouth, Minnesota, 55442,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ev3

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ev3 is included in 1 Expert Collection, including Medical Devices.


Medical Devices

3,383 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

ev3 Patents

ev3 has filed 35 patents.

patents chart

Application Date

Grant Date


Related Topics




Interventional radiology, Catheters, Endoscopy, Surgical procedures and techniques, Implants (medicine)


Application Date


Grant Date



Related Topics

Interventional radiology, Catheters, Endoscopy, Surgical procedures and techniques, Implants (medicine)



Latest ev3 News

Medical Wire Loop Snares Market Features of Investment Opportunities and Future Trends To 2027 – Cook Medical, Covidean, EV3 and Merit Medical

Mar 25, 2021

A wire loop for is used for removing polyps and other pedunculated growths by cutting them off at the base. An instrument is used for removing polyps and other projections from a surface, especially within a cavity; it consists of a wire loop passed around the base of the tumor and gradually tightened. By SMN Bureau The Insight Partners provides you global research analysis on “Medical Wire Loop Snares Market” and forecast to 2027. The research report provides deep insights into the global market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of the Medical Wire Loop Snares Market during the forecast period, i.e., 2020–2027. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Medical Wire Loop Snares Market. The researcher provides an extensive analysis of the Medical Wire Loop Snares Market size, share, trends, overall earnings, gross revenue, and profit margin to accurately draw a forecast and provide expert insights to investors to keep them updated with the trends in the market. Download a Sample Report Explore further @  https://www.theinsightpartners.com/sample/TIPRE00010480/ A wire loop for is used for removing polyps and other pedunculated growths by cutting them off at the base. An instrument is used for removing polyps and other projections from a surface, especially within a cavity; it consists of a wire loop passed around the base of the tumor and gradually tightened. The medical wire loop snares market is anticipated to grow due to rising geriatric population. Moreover, changing lifestyle, rising prevalence of strokes, and increasing technological advancements in the medical devices industry is expected to boost the growth of the market in the forecast period. Key Players Influencing the Market: 1. Argon Medical Market Segmentation : The medical wire loop snares market is segmented on the basis of type, and application. Based on type the market is segmented as goose?neck snare and EN snare. On the basis of end user the market is categorized as hospitals, specialty clinics and ambulatory surgical centers. The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Medical Wire Loop Snares Market. Further, the report conducts an intricate examination of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal with regard to different segments. The report predicts the influence of different industry aspects on the Medical Wire Loop Snares Market segments and regions. The research on the Medical Wire Loop Snares Market focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors to help clients understand their competitor’s methodologies. The research also segments the Medical Wire Loop Snares Market on the basis of end user, product type, application, and demography for the forecast period 2020–2027. Comprehensive analysis of critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics. This report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the Medical Wire Loop Snares Market. Medical Wire Loop Snares Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America Request for Buy Report @  https://www.theinsightpartners.com/buy/TIPRE00010480/ Reasons to Buy the Report: Learn about the driving factors, affecting the market growth. Imbibe the advancements and progress in the market during the forecast period. Understand where the market opportunities lies. Compare and evaluate various options affecting the market. Pick up on the leading market players within the market. Envision the restrictions and restrains that are likely to hamper the market. About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense. Contact Us:

  • When was ev3 founded?

    ev3 was founded in 2000.

  • Where is ev3's headquarters?

    ev3's headquarters is located at 9600 54th Avenue North, Plymouth.

  • What is ev3's latest funding round?

    ev3's latest funding round is Acq - P2P.

  • Who are the investors of ev3?

    Investors of ev3 include Covidien, Warburg Pincus and The Vertical Group.

  • Who are ev3's competitors?

    Competitors of ev3 include OrthAlign, Tornier, Anteis, Cameron Health, Embrella Cardiovascular and 12 more.

You May Also Like


NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.

NeoChord Logo

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.

Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

Angel Medical Systems Logo
Angel Medical Systems

Angel Medical Systems has developed the AngelMed Guardian system, an implantable cardiac monitoring and alerting system that is designed to warn cardiac patients of potentially life-threatening heart conditions. The AngelMed Guardian System heart monitor is designed to track changes in the heart's electrical signal from a standard pacemaker lead, identify the signature of acute thrombotic occlusions when they occur, and then alert the patient directly to seek medical attention. The device is being studied in high risk heart patients who do not qualify for an ICD, but who have had a STEMI, NSTEMI or unstable angina in their recent past.

Embolic Protection

Devices for the prevention of embolic complications including stroke and heart attack during interventional vascular procedures. Acquired by Boston Scientific in 2001.

Es Vascular

ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.